Innovations in biomedical engineering at CU Boulder involve layering polymers to support the growth of essential cells for long-term vessel health. Cardiovascular diseases remain a critical global threat, claiming approximately 20 million lives annually and necessitating advanced surgical interventions. When natural arteries become blocked, surgeons frequently turn to synthetic vascular grafts, yet these traditional solutions often fall short. Most medical-grade grafts currently in use are manufactured from inert polymers like Teflon or various plastics. While these materials provide the immediate structural integrity required to withstand arterial blood pressure, they lack the biological complexity of natural tissue. Because they cannot repair themselves or interact dynamically with the human body, these synthetic tubes often trigger adverse reactions such as blood clots or excessive tissue growth, leading to a failure rate of nearly 50 percent within just one year of implantation.
Engineering Living Scaffolds: The Role of Electrospinning
To move beyond the limitations of static plastic tubes, the Tan Research Group at the University of Colorado Boulder is developing a vascular graft that acts as a living environment. This approach centers on a fabrication technique known as electrospinning, where specialized polymers are spun into incredibly fine nanofibers. These fibers are then woven into a sophisticated, multilayered scaffold designed to mimic the intricate architecture of a human blood vessel. Unlike the solid, impermeable walls of standard synthetic grafts, these electrospun scaffolds are porous and flexible, providing a microscopic lattice that invites the body’s own cells to migrate and take up residence. This structural mimicry is essential for ensuring that the implant is not merely a bypass route but a functional component of the patient’s circulatory system. By creating a physical environment that mirrors native tissue, the researchers aim to eliminate the biological rejection that typically characterizes traditional medical implants.
Lead researcher Associate Professor Wei Tan, alongside undergraduate student Anagha Varada, focuses on the synergy between synthetic materials and biological growth. The goal is to produce a graft that actively participates in the healing process rather than remaining a foreign object. Current progress suggests that these regenerative grafts can overcome the mechanical fatigue often seen in patients undergoing hemodialysis, where repeated needle punctures destroy traditional plastic grafts. Since the new scaffold supports the growth of native cells, it possesses the potential for self-repair, a feature entirely absent in commercial Teflon products. This transition from inert hardware to bio-integrated software represents a significant shift in how biomedical engineers approach cardiovascular repair. The integration of high-level research with undergraduate talent through programs like SPUR ensures a steady influx of innovative perspectives, driving the development of these solutions toward clinical applications.
Clinical Performance: Results and Future Applications
The specialized functionality of the CU Boulder graft is achieved through a deliberate dual-layer design that serves two distinct physiological purposes. The innermost section, referred to as the endothelial layer, is engineered to host a thin coating of endothelial cells. In a healthy natural vessel, these cells provide a perfectly smooth interface that prevents blood components from sticking to the walls. In synthetic grafts, the lack of this living barrier often leads to friction and chemical triggers that cause thrombosis, or blood clotting. By providing a scaffold specifically tuned for endothelial cell attachment, the research team ensures that the graft maintains a low-friction surface that naturally resists blockages. This biological interface is critical for long-term patency, as it prevents the initial inflammatory triggers that eventually lead to the total occlusion of the vessel. Consequently, the graft functions more like a biological extension of the heart’s network.
The successful demonstration of these regenerative blood vessels marked a turning point in the development of long-term solutions for heart disease and hemodialysis patients. Researchers identified that the next critical phase involved scaling the electrospinning process to produce grafts suitable for larger human vessels while maintaining the precision of the nanofiber layers. The project established a framework for future biomedical innovations that prioritize biological synergy over material durability alone. Moving forward, the scientific community began exploring how these living scaffolds might be infused with growth factors to further accelerate the integration process in older patients with slower healing rates. This research did not just provide a new medical device; it offered a sustainable model for tissue engineering that aimed to reduce the global burden of cardiovascular failure. By focusing on the body’s natural ability to regenerate, the team at CU Boulder set the stage for a new era of self-sustaining medical implants.
